Weekly CSR Email Newsletter
Distribute Press Releases To Chinese Media!Getting your company's message to journalists is important in China and ChinaNewswire.com can assist you in English-language releases and Xinwengao.com can provide Chinese-language distribution services. Corporate press releases are the most cost-effective way for you to connect with your customers and stakeholders in China!
• Global CSR Summit 2009 @ Singapore - 2009/01/13
• 2nd Annual Anti-Corruption Asia Congress @ Hong Kong - 2009/01/19
• Outsourcing Asia Summit 2009 @ Singapore - 2009/02/18
• Anti-Monopoly & Competition Law Asia Forum @ Hong Kong - 2009/02/24
• Ultra High-rise Buildings Summit @ Shanghai - 2009/03/26
• Export Control and Trade Compliance Asia Summit @ Beijing - 2009/04/21
Let us work with you in China to manage your email marketing campaigns, loyalty marketing programs, email newsletters, and digital marketing efforts while we improve your email deliverability in China. Our software and staff can help your company stay #1! Visit XZList.com
China SFDA Approves Clinical Trials To Combat Antibiotic Resistant Infection
October 30, 2008 |
Print
| 
Email
| Category: Health
Haikou based China Pharma Holdings,has received approval from China's State Food and Drug Administration to start clinical trials of a combination of an antibiotic with a bacterial-enzyme inhibitor.
The company will initiate clinical trials in November 2008 to evaluate this drug, a third generation Cephalosporin antibiotic combined with a bacterial-enzyme inhibitor, for the treatment of infections.
China Pharma's CEO and president, Zhilin Li, commented that the company was pleased that the SFDA had given approval for their new antibiotic formula to enter clinical trials. She added that they look forward to initiating and completing these clinical trials over the next two years and hope to confirm previous results that showed significant efficacy in clearing antibiotic resistant bacterial strains.
Microbial antibiotic resistance has emerged as a major public health problem in China and throughout the world. Many Cephalosporins marketed in China, including third generation Cephalosporins, have encountered bacterial resistance. Surveys in China up to 2005 shows that 20% to 70% of certain target pathogen strains may be resistant to one or more third generation Cephalosporins. Despite this drug resistance, China's market for Cephalosporin antibiotics was approximately CNY 25.2 billion in 2006 and is predicted to exceed CNY 38.3 billion in 2008.
No Ratings Yet
Rate this page: 
Loading ...Leave A Comment:
-
Business & Society
-
Consumer
-
Education
- CUG Offers One-stop Service For Students
- China To Provide Scholarships For SUNY Undergraduates
- China To Help Pay Tuition Fee And Loans For College Graduates Going West
- ME Invests CNY4.4 Billion To Speed Up Education In Middle And West China
- Johnson Controls Works With SIFE China To Help Build Future Business Leaders
-
Happenings
-
Health
-
Labor
- Staff Claim Compensation From Sony Ericsson In Beijing
- Macau Companies Rush To Sign Labor Contracts With Employees
- Multinational Companies Must Not Delay Establishment Of Trade Unions In China
- China Will Give High Priority To College Graduates' Employment
- Manufacturer Wins Right To Dismiss Trade Union Chief In China
-
Law & Order
-
Viewpoints
- Global Financial Woes May Impact Corporate Social Responsibility In China
- Harmonious Corporate Social Responsibility In China: More Prophesy Than Reality?
- Year Of The Rat Brings A Plague Upon Employers In China
- Incorporating Healthcare Into CSR Programs
- MBA Toolkit For CSR: Government Relations And Public Affairs
Copyright 2003-2009 ChinaCSR.com. All Rights Reserved.
ChinaCSR.com is a service of BDL Media Ltd. If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website, in whole or in part, is expressly prohibited without express written permission from BDL Media.
